How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of caval valve implantation for tricuspid regurgitation

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Dreger H, Mattig I, Hewing B, Knebel F et al. (2020) Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial. EuroIntervention 15: 1506–13

    2. Hewing B, Mattig I, Knebel F et al. (2021) Renal and hepatic function of patients with severe tricuspid regurgitation undergoing inferior caval valve implantation. Sci Rep 8;11(1): 21800

    3. Lauten A, Figulla HR, Unbehaun A et al. (2018) Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv 11: e006061

    4. Estévez-Loureiro R, Sanchez-Recalde A, Amat-Santos IJ et al. (2022) 6-month outcomes of the TricValve system in patients with tricuspid regurgitation: the TRICUS EURO study. J Am Coll Cardiol Int 15: 1366–77

    5. Wild MG, Lubos E, Cruz-Gonzalez I et al. (2022) Early clinical experience with the TRICENTO bicaval valved stent for treatment of symptomatic severe tricuspid regurgitation: a multicenter registry. Circ Cardiovasc Interv 15: e011302

    6. O'Neill B, Negrotto S, Yu D et al. (2020) Cava valve implantation for tricuspid regurgitation: insights from the United States caval valve registry. J Invasive Cardiol 32:470–5

    7. Wilbring M, Tomala J, Ulbrich S et al. (2020) Recurrence of right heart failure after heterotopic tricuspid intervention: a conceptual misunderstanding? JACC Cardiovasc Interv 13: e95–6